Overview

Study of Cardiovascular Disease and Obstructive Sleep Apnea

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if two medicines (allopurinol and losartan) can influence heart and blood vessel health compared to placebo in patients with sleep apnea who are using continuous positive airway pressure (CPAP).
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Allopurinol
Losartan